Sort
8,912 grants matching “sars cov 2”
Alphavirus Vectored Vaccines for the SARS Coronavirus
$269,313Robert E. Johnston · Univ Of North Carolina Chapel Hill · P01 · FY2006 · AI
Pathogenesis and immunity during SARS-CoV-2 infection
$269,212Julie Fox · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
The T32 Predoctoral Training Program in Immunology (PTPI)
$269,048Jacques Robert · University Of Rochester · T32 · FY2023 · AI
High Dimensional Imaging of Postmortem Human Covid-19 Autopsy Samples to Evaluate Pathophysiology and Immunology of SARS-CoV-2
$268,882Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Conjugate vaccines for prevention and treatment of cryptococcosis - COVID-19 Revision Supplement
$268,837Arturo Casadevall · Johns Hopkins University · R01 · FY2021 · AI
Infection and Immunity: The Pathogenesis of Host-Microbe Interactions
$268,773Paul M. Dunman · University Of Rochester · T32 · FY2023 · AI
Infection and Immunity: The Pathogenesis of Host-Microbe Interactions
$268,680Paul M. Dunman · University Of Rochester · T32 · FY2024 · AI
Admin Core
$268,355Scott Dexter Boyd · Stanford University · U54 · FY2020 · CA
The RCMI Program in Health Disparities Research at Meharry Medical College
$268,287Samuel E. Adunyah · Meharry Medical College · U54 · FY2021 · MD
Admin Core
$268,287Maria F Lima · Meharry Medical College · U54 · FY2021 · MD
Investigating the roles of Topoisomerase 3b-TDRD3 complex in neurodegeneration and Alzheimer's disease
$268,210Weidong Wang · National Institute On Aging · ZIA · FY2023 · AG
Antiviral T cell Responses During SARS-CoV-2 Infection
$267,943Heather Hickman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Mechanistic & Crystallographic Studies of SARS Proteases
$267,681Andrew D Mesecar · University Of Illinois At Chicago · P01 · FY2009 · AI
1/4 Investigation of opioid exposure and neurodevelopment (iOPEN)
$267,279Alice M Graham · Oregon Health & Science University · R34 · FY2021 · DA
Effects of Exogenous Hormone Treatment on Vaccine Responses
$267,121Sara Lustigman · New York Blood Center · R21 · FY2025 · AI
Prospective predictors of risk and resilience trajectories of mental health in US youth during COVID-19
$267,000Ran Barzilay · Children'S Hosp Of Philadelphia · R21 · FY2023 · MH
CORE 2: Technology Core
$266,760Danielle L Swaney · University Of California, San Francisco · U19 · FY2025 · AI
Infection and Immunity: The Pathogenesis of Host-Microbe Interactions
$266,460Paul M. Dunman · University Of Rochester · T32 · FY2025 · AI
Genomics Core
$266,306Robert Sebra · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AI
Shark nanobodies enable identification of pan-sarbecovirus and pan-merbecovirus spike RBD sites of vulnerability
$266,262Helen M. Dooley · University Of Maryland Baltimore · R21 · FY2023 · AI
EAGER: Device for Prevention of Endotracheal Tube Biofilm Formation for the Prevention of Ventilator Associated Pneumonia
$266,161Eric J Seibel · University Of Washington · · FY2020 · ENG
Deciphering the Double-Edged Role of IFITM3 during SARS-CoV-2 Infection
$265,660Alex Compton · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
COVIDgene: Host genetics of SARS_CoV_2 infections
$265,558David L Thomas · Johns Hopkins University · R01 · FY2021 · AI
Rapid antibody screening systems to identify and engineer antiviral protection
$265,139Brandon James Dekosky · Massachusetts General Hospital · R21 · FY2022 · AI
Mechanistic elucidation of inflammasome assembly and regulation. Supplement: Testing drugs that curtail inflammasome activation to suppress SARS-CoV-2 pathogenesis
$264,999Hao Wu · Boston Children'S Hospital · R01 · FY2020 · AI